These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22362486)

  • 1. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study.
    Su H; Tao J; Zhang J; Xie Y; Wang Y; Zhang Y; Han B; Lu Y; Sun H; Wei Y; Zou S; Wu W; Zhang J; Xu K; Zhang X; He J
    J Clin Psychopharmacol; 2015 Oct; 35(5):517-24. PubMed ID: 26280836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of smoking on cognition and BDNF levels in a male Chinese population: relationship with BDNF Val66Met polymorphism.
    Xia H; Du X; Yin G; Zhang Y; Li X; Cai J; Huang X; Ning Y; Soares JC; Wu F; Zhang XY
    Sci Rep; 2019 Jan; 9(1):217. PubMed ID: 30659208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
    Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients.
    Chung S; Chung HY; Jung J; Chang JK; Hong JP
    Compr Psychiatry; 2010; 51(4):367-72. PubMed ID: 20579509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
    Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
    Zhang XY; Chen DC; Tan YL; Luo X; Zuo L; Lv MH; Shah NN; Zunta-Soares GB; Soares JC
    J Psychiatr Res; 2015 Jan; 60():49-55. PubMed ID: 25455509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
    Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
    Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.
    Lu W; Zhang C; Yi Z; Li Z; Wu Z; Fang Y
    J Mol Neurosci; 2012 Jul; 47(3):505-10. PubMed ID: 22477643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
    Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Wang TY; Chen PS; Lee IH; Yang YK; Hong JS; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():99-104. PubMed ID: 24468644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.
    Szabo AJ; Alosco ML; Miller LA; McGeary JE; Poppas A; Cohen RA; Gunstad J
    Psychogeriatrics; 2013 Dec; 13(4):206-12. PubMed ID: 24289461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognition, serum BDNF levels, and BDNF Val66Met polymorphism in type 2 diabetes patients and healthy controls.
    Zhen YF; Liu XY; Zhou DH; Du X; Yin G; Zhang Y; Fang H; Xu G; Soares JC; Zhang XY
    Oncotarget; 2018 Jan; 9(3):3653-3662. PubMed ID: 29423073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
    Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
    Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCF4 gene polymorphism is associated with cognition in patients with schizophrenia and healthy controls.
    Hui L; Rao WW; Yu Q; Kou C; Wu JQ; He JC; Ye MJ; Liu JH; Xu XJ; Zheng K; Ruan LN; Liu HY; Hu WM; Shao TN; AngRabanes MB; Soares JC; Zhang XY
    J Psychiatr Res; 2015 Oct; 69():95-101. PubMed ID: 26343600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of brain-derived neurotrophic factor-catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms.
    Han DH; Park DB; Choi TY; Joo SY; Lee MK; Park BR; Nishimura R; Chu CC; Renshaw PF
    Neuroreport; 2008 Jul; 19(11):1155-8. PubMed ID: 18596619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
    Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BDNF Val66Met polymorphism, resting-state hippocampal functional connectivity and cognitive deficits in acute late-onset depression.
    Yin Y; Hou Z; Wang X; Sui Y; Yuan Y
    J Affect Disord; 2015 Sep; 183():22-30. PubMed ID: 26000753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.